Koçak, Mehmet ZahidAktaş, GülaliErkuş, EdipDuman, Tuba T.Atak, Burçin M.Şahin, DenizŞavlı, Haluk2021-06-232021-06-2320181022-386X1681-7168https://hdl.handle.net/20.500.12491/9630https://www.jcpsp.pk/archive/2018/Apr2018/23.pdf?Acute pancreatitis (AP) is characterised by inflammatory destruction of the gland due to early activation of the pancreatic proteolytic enzymes. Drug-induced AP accounts for only 0.1-2 % of AP.1 One of these drugs is dipeptidyl peptidase-4 inhibitor (DPP-4i). Association between AP and Sitagliptin, a DPP-4i, was initially described in a transgenic rat model.2 We aim to present a case of AP in a diabetic elderly, which was likely associated with Sitagliptin treatment.eninfo:eu-repo/semantics/closedAccessAcute PancreatitisLetter28433433429615184WOS:000429556100023Q4